Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care

B Glintborg; T Kringelbach; N Bolstad; D J Warren; G Eng; I J Sørensen; A G Loft; O Hendricks; I Hansen; A Linauskas; H Nordin; S Kristensen; H Lindegaard; D V Jensen; G L Goll; E Høgdall; J Gehin; C Enevold; C H Nielsen; N S Krogh; J S Johansen; M L Hetland

doi:10.1080/03009742.2017.1376110

Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care

B Glintborg, T Kringelbach, N Bolstad, D J Warren, G Eng, I J Sørensen, A G Loft, O Hendricks, I Hansen, A Linauskas, H Nordin, S Kristensen, H Lindegaard, D V Jensen, G L Goll, E Høgdall, J Gehin, C Enevold, C H Nielsen, N S KroghJ S Johansen, M L Hetland

9 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Scandinavian Journal of Rheumatology
Vol/bind	47
Udgave nummer	5
Sider (fra-til)	418-421
Antal sider	4
ISSN	0300-9742
DOI	https://doi.org/10.1080/03009742.2017.1376110
Status	Udgivet - sep. 2018

Adgang til dokumentet

10.1080/03009742.2017.1376110

Andre filer og links

Link to publication in Scopus

Citationsformater

Glintborg, B., Kringelbach, T., Bolstad, N., Warren, D. J., Eng, G., Sørensen, I. J., Loft, A. G., Hendricks, O., Hansen, I., Linauskas, A., Nordin, H., Kristensen, S., Lindegaard, H., Jensen, D. V., Goll, G. L., Høgdall, E., Gehin, J., Enevold, C., Nielsen, C. H., ... Hetland, M. L. (2018). Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care. Scandinavian Journal of Rheumatology, 47(5), 418-421. https://doi.org/10.1080/03009742.2017.1376110

Glintborg, B, Kringelbach, T, Bolstad, N, Warren, DJ, Eng, G, Sørensen, IJ, Loft, AG, Hendricks, O, Hansen, I, Linauskas, A, Nordin, H, Kristensen, S, Lindegaard, H, Jensen, DV, Goll, GL, Høgdall, E, Gehin, J, Enevold, C, Nielsen, CH, Krogh, NS, Johansen, JS & Hetland, ML 2018, 'Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care', Scandinavian Journal of Rheumatology, bind 47, nr. 5, s. 418-421. https://doi.org/10.1080/03009742.2017.1376110

@article{bd0cf35a71db483b9e34d77f5d3f58c2,

title = "Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care",

author = "B Glintborg and T Kringelbach and N Bolstad and Warren, \{D J\} and G Eng and S{\o}rensen, \{I J\} and Loft, \{A G\} and O Hendricks and I Hansen and A Linauskas and H Nordin and S Kristensen and H Lindegaard and Jensen, \{D V\} and Goll, \{G L\} and E H{\o}gdall and J Gehin and C Enevold and Nielsen, \{C H\} and Krogh, \{N S\} and Johansen, \{J S\} and Hetland, \{M L\}",

note = "COPECARE",

year = "2018",

month = sep,

doi = "10.1080/03009742.2017.1376110",

language = "English",

volume = "47",

pages = "418--421",

journal = "Scandinavian Journal of Rheumatology",

issn = "0300-9742",

publisher = "Taylor and Francis Ltd.",

number = "5",

}

TY - JOUR

T1 - Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care

AU - Glintborg, B

AU - Kringelbach, T

AU - Bolstad, N

AU - Warren, D J

AU - Eng, G

AU - Sørensen, I J

AU - Loft, A G

AU - Hendricks, O

AU - Hansen, I

AU - Linauskas, A

AU - Nordin, H

AU - Kristensen, S

AU - Lindegaard, H

AU - Jensen, D V

AU - Goll, G L

AU - Høgdall, E

AU - Gehin, J

AU - Enevold, C

AU - Nielsen, C H

AU - Krogh, N S

AU - Johansen, J S

AU - Hetland, M L

N1 - COPECARE

PY - 2018/9

Y1 - 2018/9

UR - https://www.scopus.com/pages/publications/85041100492

U2 - 10.1080/03009742.2017.1376110

DO - 10.1080/03009742.2017.1376110

M3 - Letter

C2 - 29310493

SN - 0300-9742

VL - 47

SP - 418

EP - 421

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

IS - 5

ER -